A quantitative comparison of metabolite signals as detected by in vivo MRS with ex vivo 1H HR-MAS for childhood brain tumours

NMR in Biomedicine

Volumn 22, Issue 2, 2009, Pages 213-219

  Wilson, Martin ^a,b   Davies, Nigel P ^a,b,c   Grundy, Richard G ^d   Peet, Andrew C ^a,b  

^a BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

^b BIRMINGHAM CHILDREN S HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^d UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

1H; Brain; High resolution magic angle spinning (HR MAS); LCModel; MRS; Paediatric; TARQUIN; Tumour

Indexed keywords

1H; HIGH-RESOLUTION MAGIC ANGLE SPINNING (HR-MAS); LCMODEL; MRS; PAEDIATRIC; TARQUIN; TUMOUR;

BIOMOLECULES; BIOPSY; CONTROL THEORY; CRAMER-RAO BOUNDS; METABOLISM; METABOLITES; ONCOLOGY; PEDIATRICS; SUGARS; TRANSPLANTS;

TUMORS;

ALANINE; ASPARTIC ACID; CHOLINE; CREATININE; GLUTAMIC ACID; GLUTAMINE; GLYCEROPHOSPHORYLCHOLINE; GLYCINE; INOSITOL; LACTIC ACID; N ACETYLASPARTIC ACID; PHOSPHORYLCHOLINE; SCYLLO INOSITOL; TAURINE; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; PROTON; TUMOR MARKER;

ACCURACY; ARTICLE; ASTROCYTOMA; CANCER SURGERY; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CLINICAL EVALUATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DATA ANALYSIS; EPENDYMOMA; EX VIVO STUDY; HUMAN; HUMAN TISSUE; IN VIVO STUDY; INTERMETHOD COMPARISON; MEASUREMENT ERROR; MEDULLOBLASTOMA; METABOLIC REGULATION; METABOLISM; METABOLITE; PRIORITY JOURNAL; PROTON HIGH RESOLUTION MAGIC ANGLE SPINNING NUCLEAR MAGNETIC RESONANCE; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE ANALYSIS; RELIABILITY; SIGNAL DETECTION; SIGNAL NOISE RATIO; SIGNAL PROCESSING; TUMOR BIOPSY; TUMOR DIAGNOSIS; BRAIN; BRAIN TUMOR; COMPARATIVE STUDY; EVALUATION; FEMALE; MALE; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

EQUUS ASINUS;

BRAIN; BRAIN NEOPLASMS; CHILD; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PROTONS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 64549092952     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.1306     Document Type: Article

References (25)

1. Choi CG, Frahm J. Localized proton MRS of the human hippocampus: metabolite concentrations and relaxation times. Magn Reson Med 1999; 41(1): 204-207.
2. Panigrahy A, Nelson MD Jr., Finlay JL, Sposto R, Krieger MD, Gilles FH, Bluml S. Metabolism of diffuse intrinsic brainstem gliomas in children. Neuro Oncol 2008; 10(1): 32-44.
3. Cordery RJ, MacManus D, Godbolt A, Rossor MN, Waldman AD. Short TE quantitative proton magnetic resonance spectroscopy in variant Creutzfeldt-Jakob disease. Eur Radiol 2006; 16(8): 1692-1698.
4. Staffen W, Zauner H, Mair A, Kutzelnigg A, Kapeller P, Stangl H, Raffer E, Niederhofer H, Ladurner G. Magnetic resonance spectroscopy of memory and frontal brain region in early multiple sclerosis. J Neuropsychiatry Clin Neurosci 2005; 17(3): 357-363.
5. Chang L, Lee PL, Yiannoutsos CT, Ernst T, Marra CM, Richards T, Kolson D, Schifitto G, Jarvik JG, Miller EN, Lenkinski R, Gonzalez G, Navia BA. A multicenter in vivo proton-MRS study of HIV-associated dementia and its relationship to age. Neuroimage 2004; 23(4): 1336-1347.
6. Frederick BD, Lyoo IK, Satlin A, Ahn KH, Kim MJ, Yurgelun-Todd DA, Cohen BM, Renshaw PF. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry 2004; 28(8): 1313-1322.
7. Peet AC, Davies NP, Ridley L, Brundler MA, Kombogiorgas D, Lateef S, Natarajan K, Sgouros S, MacPherson L, Grundy RG. Magnetic resonance spectroscopy suggests key differences in the metastatic behaviour of medulloblastoma. Eur J Cancer 2007; 43: 1037-1044.
8. Panigrahy A, Krieger MD, Gonzalez-Gomez I, Liu X, McComb JG, Finlay JL, Nelson MD Jr., Gilles FH, Bluml S. Quantitative short echo time 1H-MR spectroscopy of untreated pediatric brain tumors: preoperative diagnosis and characterization. AJNR Am J Neuroradiol 2006; 27(3): 560-572.
9. Astrakas LG, Zurakowski D, Tzika AA, Zarifi MK, Anthony DC, De Girolami U, Tarbell NJ, Black PM. Noninvasive magnetic resonance spectroscopic imaging biomarkers to predict the clinical grade of pediatric brain tumors. Clin Cancer Res 2004; 10: 8220-8228.
10. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993; 30(6): 672-679.
11. Cheng LL, Becerra L, Ptak T, Tracey I, Lackner A, Gonzalez RG. Quantitative neuropathology by high resolution magic angle spinning proton magnetic resonance spectroscopy. Proc Natl Acad. Sci USA 1996; 96: 1023-1031.
12. Sitter B, Sonnewald U, Spraul M, Fjosne HE, Gribbestad IS. High-resolution magic angle spinning MRS of breast cancer tissue. NMR Biomed 2002; 15(5): 327-337.
13. Sitter B, Lundgren S, Bathen TF, Halgunset J, Fjosne HE, Gribbestad IS. Comparison of HR MAS MR spectroscopic profiles of breast cancer tissue with clinical parameters. NMR Biomed 2006; 19(1): 30-40.
14. 1H MR spectroscopy for assessment of apoptosis in cervical carcinomas. BMC Cancer 2007; 7: 11.
15. 1H NMR spectroscopy in conjunction with multivariate data analysis. J Proteome Res 2007; 6(7): 2605-2614.
16. 1H NMR spectroscopy. NMR Biomed 2006; 19(1): 90-100.
17. 1H MRS study of human high grade gliomas. NMR Biomed 2004; 17: 191-205.
18. Tzika AA, Astrakas L, Cao H, Mintzopoulos D, Andronesi OC, Mindrinos M, Zhang J, Rahme LG, Blekas KD, Likas AC, Galatsanos NP, Carroll RS, Black PM. Combination of high-resolution magic angle spinning proton magnetic resonance spectroscopy and microscale genomics to type brain tumor biopsies. Int J Mol Med 2007; 20(2): 199-208.
19. 1H MRS of human brain tumours with 1H HR-MAS spectroscopy of intact biopsy samples in vitro. MAGMA 1999; 8(2): 121-128.
20. Sjobakk ET, Johansen R, Bathen TF, Sonnewald U, Juul R, Torp SH, Lundgren S, Gribbestad IS. Characterization of brain metastases using high-resolution magic angle spinning MRS. NMR Biomed 2008; 21(2): 175-185.
21. Tzika AA, Cheng LL, Goumnerova L, Madsen JR, Zurakowski D, Astraks LG, Zarifi MK, Scott RM, Anthony DC, Gonzalez RG, Black P. Biochemical characterization of pediatric brain tumours by using in vivo and ex vivo magnetic resonance spectroscopy. J Neurosurg 1996; 96: 1023-1031.
22. Tugnoli V, Schenetti L, Mucci A, Nocetti L, Toraci C, Mavilla L, Basso G, Rovati R, Tavani F, Zunarelli E, Righi V, Tosi MR. A comparison between in vivo and ex vivo HR-MAS 1H MR spectra of a pediatric posterior fossa lesion. Int J Mol Med 2005; 16(2): 301-307.
23. 1H nuclear magnetic resonance spectroscopy. Magn Reson Med 2005; 53(5): 1018-1024.
24. Reynolds G, Wilson M, Peet A, Arvanitis TN. An algorithm for the automated quatitation of metabolites in in vitro NMR signals. Magn Reson Med 2006; 56(6): 1211-1219.
25. Kleihues P, Cavanee WK. World Health Organization Classification of Tumours. International Agency for Research on Cancer: Geneva,2000.